Elequin Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-45,072
Closed -$613K 173
2025
Q2
$613K Buy
45,072
+37,993
+537% +$543K 0.08% 87
2025
Q1
$105K Buy
7,079
+1,214
+21% +$19K 0.01% 129
2024
Q4
$84.5K Buy
+5,865
New +$90.8K 0.01% 121
2024
Q1
Sell
-17,776
Closed -$260K 271
2023
Q4
$260K Buy
+17,776
New +$248K 0.08% 95
2023
Q2
Sell
-4,500
Closed -$75.2K 549
2023
Q1
$75.2K Sell
4,500
-89,510
-95% -$1.44M 0.05% 94
2022
Q4
$1.45M Buy
+94,010
New +$1.46M 0.41% 30

Other funds holding BMEZ

Elequin Capital's BMEZ Position: Q3 2025 in Review

Elequin Capital sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2025, closing a stake of 45,072 shares — an estimated $613K sold.

Elequin Capital first reported a position in BMEZ in Q4 2022 and held it in 6 quarters. The position peaked at $1.45M in Q4 2022. 77 funds tracked by Wall St. Rank hold BMEZ as of Q3 2025.

  • Elequin Capital reported no remaining BlackRock Health Sciences Trust II position as of Q3 2025 after selling out during the quarter.
  • Elequin Capital sold 45,072 BlackRock Health Sciences Trust II shares in Q3 2025, an estimated $613K.
  • Elequin Capital first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 6 quarters.
  • Elequin Capital's BlackRock Health Sciences Trust II position peaked at $1.45M in Q4 2022.
  • 77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2025.

Based on Elequin Capital's 13F filing for Q3 2025, filed 14 Nov 2025.